Video Experimental Relacionado
Updated: Jul 24, 2026
09:33
A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Diferencia cGMP arteriovenosa plasmática como un indicador útil de la tolerancia a los nitratos en pacientes con
T Tsutamoto1, M Kinoshita, Y Ohbayashi
1First Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Circulation
|August 1, 1994
Resumen
La producción de cGMP arteriovenosa plasmática es un indicador efectivo de la presencia de nitroglicerina en el plasma.
Área de la Ciencia:
- Fisiología cardiovascular fisiología cardiovascular.
- Farmacología Farmacología.
Sus antecedentes:
- La insuficiencia cardíaca congestiva (ICF) presenta desafíos hemodinámicos complejos.
- La nitroglicerina (GTN) es un vasodilatador común utilizado en el tratamiento de la insuficiencia cardíaca congestiva.
- La tolerancia al nitrato puede limitar la eficacia a largo plazo de GTN.
Objetivo del estudio:
- Para investigar el impacto de la nitroglicerina (GTN) en la producción de monofosfato de guanosina cíclica arteriovenosa (cGMP) en el plasma.
- Para comparar los efectos hemodinámicos de GTN en pacientes con insuficiencia cardíaca congestiva (CHF).
- Evaluar la utilidad de la producción arteriovenosa plasmática de cGMP como biomarcador para la tolerancia al nitrato.
Principales métodos:
- Medición de cGMP en plasma, péptido natriurético auricular y parámetros hemodinámicos antes y después de la infusión de GTN en 14 pacientes con CHF.
- Infusión de GTN dependiente de la dosis para evaluar sus efectos en la producción de cGMP.
- Evaluación de la tolerancia hemodinámica y la producción de GMPc a las 12 y 24 horas después de la perfusión.
Principales resultados:
- La infusión de GTN aumentó la producción de GMPc arteriovenosa en plasma de una manera dependiente de la dosis.
- Se observó una correlación positiva entre la reducción de la presión de la cuña capilar pulmonar pulmonar y el aumento de la producción arteriovenosa de cGMP.
- La tolerancia hemodinámica y la producción atenuada de cGMP arteriovenoso se observaron a las 12 y 24 horas.
Conclusiones:
- La diferencia de cGMP arteriovenoso plasmático sirve como un indicador clínico de la acción vasodilatadora de GTN.
- Esta medición es una herramienta valiosa para monitorear la tolerancia a los nitratos en pacientes con insuficiencia cardíaca congestiva.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...